Targeted mass spectrometry for absolute quantification of total human β‑nerve growth factor in the development of a bispecific therapeutic antibody.

Published 10/10/2026

Research record: Targeted mass spectrometry for absolute quantification of total human β‑nerve growth factor in the development of a bispecific therapeutic antibody.

Published in J Pharm Biomed Anal; first publication date 2026-10-10. PMID 42896357.

This literature update records publication metadata from Europe PMC. Consult the original publication for its methods, findings and limitations.

Read the original publication on PubMed

Talk to a Specialist Browse all insights

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-10-10

Updated

2026-10-22

Disclaimer

professional use

References

Explore more

Droplet digital PCR as a first-line detection tool in the genetic diagnosis of vascular anomalies.

Flow cytometry of bronchoalveolar lavage fluid in the diagnostic evaluation of fibrotic nonspecific interstitial pneumonia-like interstitial lung abnormalities in a former smoker with suspected post-COVID-19 syndrome.

Review and references

Explore more

Droplet digital PCR as a first-line detection tool in the genetic diagnosis of vascular anomalies.

Flow cytometry of bronchoalveolar lavage fluid in the diagnostic evaluation of fibrotic nonspecific interstitial pneumonia-like interstitial lung abnormalities in a former smoker with suspected post-COVID-19 syndrome.

Jeffrey's Insights: Next-generation sequencing for primary immunodeficiency diagnosis, 2019-2025.